MYO News and Headlines - Myomo Inc

GuruFocus Articles Total 1
  • 1

Valeant, Xoma Corp and Myomo rose in premarket trading

Valeant Pharmaceuticals International Inc. (VRX) jumped more than 16% in premarket trading on the back of the company reporting its financial results for the third quarter. The company posted EPS of $1.04, which beat estimates by 14 cents. Revenue for the quarter was $$2.22 billion, which was lower than the $2.48 billion reported in the year-ago quarter, but it managed to beat expectations by $50 million.

"Our strong third-quarter performance demonstrates our continued progress in the turnaround of Valeant," Chairman and CEO Joseph C. Papa said. "Driven by solid execution in our Bausch + Lomb/International segment and

118 Views    Omar Venerio    2017-11-07 17:36

Headlines Total 20
  • 1

2021-05-05 $ 9.54 (-6.56%)
6:05pm
2021-04-28 $ 10.749 (3.06%)
11:34am
2021-03-24 $ 12.88 (-2.65%)
2:26pm
2021-03-12 $ 13.55 (8.49%)
2:29pm
2021-03-10 $ 12.89 (4.63%)
4:55pm
2021-03-04 $ 10.39 (-9.89%)
11:31am
2021-02-17 $ 17.04 (-6.06%)
9:55am
5:01am
2021-02-16 $ 18.14 (24.42%)
9:33am
2021-02-09 $ 12.84 (3.55%)
8:56am
8:41am
2021-01-28 $ 11.15 (0.18%)
7:02am
2021-01-27 $ 11.13 (-10.02%)
7:55am
2021-01-21 $ 10.89 (1.11%)
8:46am
2020-12-11 $ 6.51 (-1.36%)
7:35am
2020-11-20 $ 5.5 (3.58%)
6:11pm
2020-10-13 $ 4.56 (-0.87%)
6:13pm
2020-08-10 $ 3.88 (-1.02%)
5:35pm
2020-05-14 $ 4.28 (-2.06%)
4:25pm
2018-04-04 $ 101.4 (-2.59%)
7:01am
Total 20
  • 1